Published in Transfusion on May 01, 2009
Plasmapheresis in asparaginase-induced pancreatitis. Transfusion (2009) 1.38
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature (2005) 5.54
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med (2007) 3.69
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2010) 3.47
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest (2003) 3.40
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher (2013) 2.97
Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am J Respir Crit Care Med (2012) 2.47
Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion (2006) 2.45
Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry. Crit Care Med (2006) 2.44
A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion (2009) 2.26
Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest (2007) 2.11
A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion (2006) 2.04
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients. Clin Cancer Res (2009) 1.94
Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med (2007) 1.79
Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev (2008) 1.61
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol (2011) 1.57
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma (2009) 1.56
Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int (2014) 1.52
The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts. Transfusion (2008) 1.49
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion (2004) 1.43
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy. J Immunother (2011) 1.41
Overnight, room temperature hold of whole blood followed by 42-day storage of red blood cells in additive solution-7. Transfusion (2014) 1.39
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion (2012) 1.38
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2007) 1.38
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant (2008) 1.37
Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol (2002) 1.30
American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia. Clin Infect Dis (2013) 1.29
A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood (2008) 1.25
Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr (2011) 1.23
Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med (2014) 1.11
Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD). J Clin Apher (2005) 1.11
Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr (2010) 1.10
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Eur J Haematol (2009) 1.09
Pooled platelet concentrates or apheresis platelets? N Engl J Med (2013) 1.07
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 1.06
Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation (2002) 1.05
Red blood cell alloantibodies: a 45-year historical review at a rural tertiary care center. Transfusion (2012) 1.05
The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher (2011) 1.04
Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apher (2013) 1.00
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl (2009) 1.00
Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest (2016) 0.97
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol (2010) 0.97
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization. Biol Blood Marrow Transplant (2012) 0.95
Early predictors of massive transfusion in patients sustaining torso gunshot wounds in a civilian level I trauma center. J Trauma (2010) 0.93
Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang. Clin Cancer Res (2007) 0.93
Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion (2008) 0.93
Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. Transfusion (2011) 0.92
Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria. Transfusion (2005) 0.91
Balancing risk and benefit: maintenance of a thawed Group A plasma inventory for trauma patients requiring massive transfusion. J Trauma Acute Care Surg (2013) 0.91
Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST). Transfusion (2012) 0.90
Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics. J Clin Microbiol (2002) 0.89
The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg (2011) 0.88
Outcomes after massive transfusion in nontrauma patients in the era of damage control resuscitation. Am Surg (2012) 0.88
Massive transfusion: blood component ratios. Curr Opin Hematol (2013) 0.87
A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation (2005) 0.87
A randomized controlled trial comparing autologous radiolabeled in vivo platelet (PLT) recoveries and survivals of 7-day-stored PLT-rich plasma and buffy coat PLTs from the same subjects. Transfusion (2011) 0.86
Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature. J Clin Apher (2012) 0.86
Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process. Transfusion (2011) 0.86
Blood donations motivators and barriers: a descriptive study of African American and white voters. Transfus Apher Sci (2012) 0.86
Paired comparison of Gambro Trima Accel versus Baxter Amicus single-needle plateletpheresis. Transfusion (2004) 0.86
Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass. J Thorac Cardiovasc Surg (2013) 0.86
Base deficit as a marker of survival after traumatic injury: consistent across changing patient populations and resuscitation paradigms. J Trauma Acute Care Surg (2012) 0.85
Interlaboratory assessment of a novel colony-forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative. Transfusion (2011) 0.84
Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion (2011) 0.84
The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher (2007) 0.83
The mechanisms of action of plasma exchange. Br J Haematol (2013) 0.83
Contribution of attitudinal factors to blood donation in African American church attendees. Transfusion (2010) 0.83
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion (2014) 0.82
A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy. J Clin Apher (2007) 0.82
Development of common metrics for donation attitude, subjective norm, perceived behavioral control, and intention for the blood donation context. Transfusion (2013) 0.82
The blood donor identity survey: a multidimensional measure of blood donor motivations. Transfusion (2014) 0.81
Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion (2013) 0.81
Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. Am J Hematol (2012) 0.81
The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion (2014) 0.81
The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit. Am J Hematol (2007) 0.81
Category IV indications for therapeutic apheresis: ASFA fourth special issue. J Clin Apher (2007) 0.81
Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature. J Clin Apher (2011) 0.81
Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective computerized order auditing. Transfusion (2014) 0.80
Routine bacterial screening of apheresis platelets on Day 4 using a rapid test: a 4-year single-center experience. Transfusion (2013) 0.80
Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results. Trans Am Ophthalmol Soc (2006) 0.80
Between the trash can and the freezer: donor education and the fate of cord blood. Transfusion (2011) 0.79
Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator. J Clin Apher (2004) 0.79
Emerging Infections and Blood Safety in the 21st Century. Ann Intern Med (2016) 0.79
Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Cytotherapy (2013) 0.79
Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion (2013) 0.79
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collected. Cytotherapy (2010) 0.79
A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide-frozen autologous platelets in healthy volunteers. Transfusion (2012) 0.79
Method to assess fatty acid ethyl ester binding to albumin. Alcohol Alcohol (2006) 0.78
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78